199 related articles for article (PubMed ID: 19143499)
1. Magnetic separation of melanoma-specific cytotoxic T lymphocytes from a vaccinated melanoma patient's blood using MHC/peptide complex-conjugated bacterial magnetic particles.
Takahashi M; Akiyama Y; Ikezumi J; Nagata T; Yoshino T; Iizuka A; Yamaguchi K; Matsunaga T
Bioconjug Chem; 2009 Feb; 20(2):304-9. PubMed ID: 19143499
[TBL] [Abstract][Full Text] [Related]
2. Direct magnetic separation of immune cells from whole blood using bacterial magnetic particles displaying protein G.
Takahashi M; Yoshino T; Takeyama H; Matsunaga T
Biotechnol Prog; 2009; 25(1):219-26. PubMed ID: 19197981
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
[TBL] [Abstract][Full Text] [Related]
4. Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane.
Yoshino T; Hirabe H; Takahashi M; Kuhara M; Takeyama H; Matsunaga T
Biotechnol Bioeng; 2008 Oct; 101(3):470-7. PubMed ID: 18421798
[TBL] [Abstract][Full Text] [Related]
5. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
Zhang XM; Zhang YF; Huang Y; Qu P; Ma B; Si SY; Li ZS; Li WX; Li X; Ge W; Hu PZ; Sui YF
Oncol Rep; 2008 Jul; 20(1):245-52. PubMed ID: 18575744
[TBL] [Abstract][Full Text] [Related]
6. Magnetic separation of CD14+ cells using antibody binding with protein A expressed on bacterial magnetic particles for generating dendritic cells.
Matsunaga T; Takahashi M; Yoshino T; Kuhara M; Takeyama H
Biochem Biophys Res Commun; 2006 Dec; 350(4):1019-25. PubMed ID: 17045961
[TBL] [Abstract][Full Text] [Related]
7. High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.
Meidenbauer N; Zippelius A; Pittet MJ; Laumer M; Vogl S; Heymann J; Rehli M; Seliger B; Schwarz S; Le Gal FA; Dietrich PY; Andreesen R; Romero P; Mackensen A
Cancer Res; 2004 Sep; 64(17):6319-26. PubMed ID: 15342421
[TBL] [Abstract][Full Text] [Related]
8. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
Li J; Mookerjee B; Wagner J
J Immunother; 2008 Jan; 31(1):81-8. PubMed ID: 18157015
[TBL] [Abstract][Full Text] [Related]
9. HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice.
Motomura Y; Ikuta Y; Kuronuma T; Komori H; Ito M; Tsuchihara M; Tsunoda Y; Shirakawa H; Baba H; Nishimura Y; Kinoshita T; Nakatsura T
Int J Oncol; 2008 May; 32(5):985-90. PubMed ID: 18425324
[TBL] [Abstract][Full Text] [Related]
10. Magnetic cell separation using antibody binding with protein a expressed on bacterial magnetic particles.
Kuhara M; Takeyama H; Tanaka T; Matsunaga T
Anal Chem; 2004 Nov; 76(21):6207-13. PubMed ID: 15516111
[TBL] [Abstract][Full Text] [Related]
11. Noncovalent immobilization of streptavidin on in vitro- and in vivo-biotinylated bacterial magnetic particles.
Maeda Y; Yoshino T; Takahashi M; Ginya H; Asahina J; Tajima H; Matsunaga T
Appl Environ Microbiol; 2008 Aug; 74(16):5139-45. PubMed ID: 18567691
[TBL] [Abstract][Full Text] [Related]
12. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
[TBL] [Abstract][Full Text] [Related]
13. In vivo biotinylation of bacterial magnetic particles by a truncated form of Escherichia coli biotin ligase and biotin acceptor peptide.
Maeda Y; Yoshino T; Matsunaga T
Appl Environ Microbiol; 2010 Sep; 76(17):5785-90. PubMed ID: 20622127
[TBL] [Abstract][Full Text] [Related]
14. Novel designs of single-chain MHC I/peptide complex for the magnetosome display system.
Honda T; Maeda Y; Yasuda T; Tanaka T; Matsunaga T; Yoshino T
Protein Eng Des Sel; 2015 Feb; 28(2):53-8. PubMed ID: 25573535
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.
Bioley G; Guillaume P; Luescher I; Bhardwaj N; Mears G; Old L; Valmori D; Ayyoub M
J Immunother; 2009; 32(2):161-8. PubMed ID: 19238015
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response.
Lu X; Jiang X; Liu R; Zhao H; Liang Z
Cancer Lett; 2008 Nov; 271(1):129-39. PubMed ID: 18621475
[TBL] [Abstract][Full Text] [Related]
17. In vivo anti-melanoma activities of the Melan-A/MART-1(101-115) T CD4+ cell peptide.
Balasse E; Gatouillat G; Patigny D; Andry MC; Madoulet C
Vaccine; 2009 Oct; 27(44):6107-9. PubMed ID: 19686694
[TBL] [Abstract][Full Text] [Related]
18. Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities.
Connerotte T; Van Pel A; Godelaine D; Tartour E; Schuler-Thurner B; Lucas S; Thielemans K; Schuler G; Coulie PG
Cancer Res; 2008 May; 68(10):3931-40. PubMed ID: 18483279
[TBL] [Abstract][Full Text] [Related]
19. An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.
Grimm KM; Trigona WL; Heidecker GJ; Joyce JG; Fu TM; Shiver JW; Keller PM; Cook JC
Protein Expr Purif; 2001 Nov; 23(2):270-81. PubMed ID: 11676602
[TBL] [Abstract][Full Text] [Related]
20. [Melanoma antigen genes(MAGE) and malignant tumors].
Xu JZ; Lin S
Ai Zheng; 2003 Sep; 22(9):1001-4. PubMed ID: 12969539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
